Skip to content

The benefit of treatment has outweighed the clinical impact of lipodystrophy, conference hears

Esteban Martinez speaking at HIV Glasgow. Image credit: HIV Drug Therapy Glasgow 2016

Middle-aged people living with HIV have an increased risk of frailty

Does HIV make you fat? Study connects viral load with fat gains

Almost three-quarters of people starting HIV therapy in Tanzania have dyslipidemia after three years of treatment

High rate of infections in people with HIV receiving Bio-Alcamid treatment for facial lipoatrophy

Reductions in visceral fat during tesamorelin therapy associated with improvements in key metabolic markers

Lipoatrophy common in children receiving d4T in South Africa

Fat accumulation linked to cognitive impairment in patients with HIV

Raltegravir kinder to bones and body fat than boosted protease inhibitors in Spanish trial